Milesta Pharma SRL
Milesta Pharma reported total assets of 15,235 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Feb 2026).
The score of Milesta Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Milesta Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 8,685 € |
| Equity | 10,685 € |
| Cash | 2,490 € |
| EBITDA | 12,576 € |
| Total assets | 15,235 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Feb 2026
Milesta Pharma's financial analysis
- Solvency70.1%sector median: 47.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Milesta Pharma
Milesta Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.477.153
- VAT number
- BE1016477153
- Peppol
- Registered · 0208:1016477153 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 2024
- Registered office
- 5651 Walcourt
- Latest accounts
- 2025 · filed on 17 Feb 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Milesta Pharma (SRL) has been based in Walcourt since 2024, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 8,685 € and equity of 10,685 €; its revenue is not published. Its solvency stands at 70.1%, above the median of its sector (47.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Milesta Pharma
Companies in the same business, of comparable size and area, outside its group.
- JABE Solutions Other business support service activities n.e.c. Ghent · balance sheet 15,095 €
- Sideways Other business support service activities n.e.c. Rumst · balance sheet 15,390 €
- Rivart Consulting Other business support service activities n.e.c. Brussels · balance sheet 15,404 €
- Restiaens Holding Other business support service activities n.e.c. Hoogstraten · balance sheet 15,060 €
- Jb² Other business support service activities n.e.c. Lint · balance sheet 15,439 €
- YALM Other business support service activities n.e.c. Vilvoorde · balance sheet 14,988 €
- Erbargu Other business support service activities n.e.c. Kortrijk · balance sheet 14,882 €
- Paloma Consult Other business support service activities n.e.c. Namur · balance sheet 14,846 €
Frequently asked questions about Milesta Pharma
What is the revenue of Milesta Pharma?
Milesta Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Milesta Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1016477153 for Milesta Pharma, if the company is VAT-registered. Its company number (CBE) is 1016.477.153.
Where is the registered office of Milesta Pharma?
According to the CBE register, the registered office of Milesta Pharma is in 5651 Walcourt.
What is the equity of Milesta Pharma?
At the close of the 2025 financial year, the equity of Milesta Pharma amounts to 10,685 €, a solvency of 70.1% of total assets.
Who manages Milesta Pharma?
The register lists 1 active mandates at Milesta Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Milesta Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →